• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Jazz Pharmaceuticals Presents Xywav® Data at Psych Congress 2024

    PR NEWSWIRE

    Enforcement Report - Week of July 24, 2024

    FDA

    Immunic Data Shows Vidofludimus Potential In Multiple Sclerosis

    PR NEWSWIRE

    EffectiCal`s Exceptional Efficacy as a Calcium Supplement

    PR NEWSWIRE

    FDA Grants ODE for Xywav Oral Solution for Idiopathic Hypersomnia in Adults

    BIOSPACE

    Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav™

    PRNEWSWIRE

     Baxter Announces USFDA Approval of Clinimix and Clinimix E

    BUSINESSWIRE

    Jazz Pharmaceuticals to Present New Data on Xywav™ Oral Solution

    PRNEWSWIRE

    Jazz Pharms` Xywav (Calcium;Magnesium:Potassium ) Receives Approval in Europe

    FDA

    Jazz Pharmaceuticals Announces U.S. FDA Approval of Xywav™

    PRNEWSWIRE

    NPPA fixes retail prices of 21 formulations under DPCO 2013

    PHARMABIZ

    NPPA fixes retail prices of 21 formulations under DPCO 2013

    PHARMABIZ

    European Commission Approves Expanded Indication For Amgen`s XGEVA® (denosumab

    PR NEWSWIRE

    Drugmaker Shire faces blood and guts battles on road to growth

    REUTERS

    Six new medicines endorsed for EU approval

    PHARMATIMES

    Artificial insulin-producing cells may help manage diabetes

    FINANCIAL EXPRESS

    Aurobindo Pharma to Acquire Select Products in France from Teva

    BUSINESS STANDARD

    Torrent Shelcal 500 found substandard, Co claims it was counterfeited

    ECONOMIC TIMES

    Marksans Pharma gets US FDA nod for Paricalcitol drug

    EXPRESS PHARMA

    US FDA Enforcement Report- 1/June/2016

    FDA

    The influence of hydrophylic polymers on the release rate of calcium dobesilate in hydrogel formulation assessed in vitro using porcine ear skin

    PHARMA-EXCIPIENTS

    Elder Pharma eyes Rs 100cr from global sales of Shelcal

    MONEY CONTROL.COM

    Shire’s $5.2 Billion Gamble Pays Off as NPS Drug Wins Approval

    BLOOMBERG

    NPS Pharm`s Natpara (Parathyroid Hormone) Approved in USA for Hypoparathyroidism

    NPS PHARMS

    Baxter Healthcare Corp., Ongoing Class II recall of Clinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections, in CLARITY Dual Chamber Container, Baxter Healthcare Corporation, Deerfield, IL NDC 0338-1115-04 because of Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.